Temper Buzz About the First Oral GLP-1 Agonist, Rybelsus

November 2019

Rybelsus (reh-BEL-sus, semaglutide) will be the first ORAL GLP-1 agonist for type 2 diabetes...it's a tablet version of injectable Ozempic.

Glucagon-like peptide-1 (GLP-1) is inactivated in the stomach.

That's why other GLP-1 agonists...Bydureon (exenatide), Trulicity (dulaglutide), Victoza (liraglutide), etc...are injected.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote